Gonadorelin

18 interactions 3 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Lenvatinib Histrelin Implant Hydroxychloroquine Inotuzumab Ozogamicin Injection Lefamulin Olodaterol Oral Inhalation
18 Major
All (18) Major (18)

Major

Gonadorelin Sertraline Explained An increased risk of QT interval prolongation Details Gonadorelin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Gonadorelin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Gonadorelin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Gonadorelin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Gonadorelin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Gonadorelin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Gonadorelin Fostemsavir Rukobia Increased risk of torsade de pointes Details Gonadorelin Glasdegib Daurismo Increased risk of QT interval prolongation Details Gonadorelin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Gonadorelin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Gonadorelin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Gonadorelin Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Gonadorelin Lefamulin Xenleta Increased risk of QT interval prolongation Details Gonadorelin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Gonadorelin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Gonadorelin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Gonadorelin Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.